Skip to main content
. 2014 Sep 23;12(9):e1001952. doi: 10.1371/journal.pbio.1001952

Table 1. Summary of the clinical phenotype of the three affected patients with DMXL2 mutations (see Figure 1 for patient numbering).

Patient #123 #124 #125
Age (years) 21.4 20.3 16.8
Weight at birth g (SDS) 2,700 (−2.2) 2,810 (−0.9) 3,060 (−1.1)
Height at birth cm (SDS) 46 (−2.5) 47 (−1.1) 49 (−0.8)
Postnatal growth retardation + + +
Height cm (SDS) 159 (−2.8) 165 (−1.8) 156 (−2.5)
Body mass index kg/m2 (SDS) 17.4 (−1.9) 21.3 (−0.2) 15.2 (−2.0)
Head circumference, cm (SDS) 54.5 (−1.9) 56 (−0.8) 51.5 (−2.5)
Ataxia + + +
Dystonia + + +
Demyelinating sensorimotor polyneuropathy + + +
Pyramidal syndrome + + +
Motor delay + + +
Dysarthria + + +
Partial frontal alopecia + + +
Intellectual disability (moderate) + + +
White matter disease (moderate subcortical, temporal) + + +
Hypoglycemia during childhood (asymptomatic) + + +
Nonautoimmune insulin-dependent diabetes mellitus + + +
Hypogonadotropic hypogonadism + + +
Low testicular volume (normal values in young adults >12 ml) 5 ml 7 ml 8 ml
Central hypothyroidism + + +
Hypoplastic pituitary gland +
Other features Progressive hearing loss

SDS, standard deviation score.